WENROVI Trademark

Trademark Overview


On Tuesday, July 3, 2018, a trademark application was filed for WENROVI with the United States Patent and Trademark Office. The USPTO has given the WENROVI trademark a serial number of 88024355. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Monday, December 23, 2019. This trademark is owned by Glaxo Group Limited. The WENROVI trademark is filed in the Pharmaceutical Products category with the following description:

(Based on Intent to Use) Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines(Based on 44(d) Priority Application) Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the tre...
wenrovi

General Information


Serial Number88024355
Word MarkWENROVI
Filing DateTuesday, July 3, 2018
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateMonday, December 23, 2019
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and Services(Based on Intent to Use) Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines(Based on 44(d) Priority Application) Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, July 9, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS

Trademark Events


Event DateEvent Description
Tuesday, December 24, 2019ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Monday, December 23, 2019ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Tuesday, June 11, 2019NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Tuesday, June 11, 2019INQUIRY TO SUSPENSION E-MAILED
Tuesday, June 11, 2019SUSPENSION INQUIRY WRITTEN
Wednesday, November 21, 2018NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Wednesday, November 21, 2018LETTER OF SUSPENSION E-MAILED
Wednesday, November 21, 2018SUSPENSION LETTER WRITTEN
Thursday, September 27, 2018ELECTRONIC RECORD REVIEW COMPLETE
Thursday, September 27, 2018PREVIOUS ALLOWANCE COUNT WITHDRAWN
Friday, September 21, 2018ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Wednesday, September 19, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, September 12, 2018ASSIGNED TO EXAMINER
Monday, July 9, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, July 6, 2018NEW APPLICATION ENTERED IN TRAM